27. Saskemycin, a potent and selective antimycobacterial agent targeting a unique site on the ribosome
Michael Cook, Min Xu, Martino Morici, Dmitrii Travin, Wenliang Wang, Dorota Klepacki, Nandini Chhabra, Vishwas Rao, Henok Sahile, Dirk Hackenberger, Haaris Safdari, Max Berger, Martina Corazza, Austin Bond, Allison Guitor, Dominique Tertigas, Lijun Wang, Adam Schaenzer, Linda Ejim, Venkateswarlu Yarlagadda, James Gomez, Michael Surette, Yossef Av-Gay, Neeraj Dhar, Deborah Hung, Nora Vázquez-Laslop, Alexander Mankin, Daniel Wilson, Gerard Wright
Manuscript under Review
26. π-Conjugated Porous Polymer Nanosheets for Explosive Sensing: Investigation on the Role of H-Bonding
Saurabh Kumar Rajput, Atul Kapoor, Abhishek Yogi, Venkateswarlu Yarlagadda, Suresh Mothika
Chemistry: An Asian Journal, 2024, 19, e202400939
Akash Dutta, Peehu Sharma, Dharam Dass, Venkatewarlu Yarlagadda*
ACS Infectious Diseases, 2024, 10, 8, 2584–2599
24. A screen of natural product extracts identifies moenomycin as a potent antigonococcal agent
V. Yarlagadda, V. N. Rao, M. Kaur, A. Guitor, G. D. Wright
ACS Infectious Diseases, 2021, 7, 1569-1577.
23. Resistance-guided discovery of elfamycin antibiotic producers with antigonococcal activity
V. Yarlagadda, R. Medina, T. Johnson, G. Cox, K. Koteva, M. N. Thaker, G. D. Wright
ACS Infectious Diseases, 2020, 6, 12, 3163–3173.
V. Yarlagadda, R. Medina, G. D. Wright
Scientific Reports, 2020, 10, 8134.
21. Vancomycin derivative inactivates carbapenem-resistant Acinetobacter baumannii and induces autophagy
P. Sarkar, S. Samaddar, V. Ammanathan, V. Yarlagadda, C. Ghosh, M. Shukla, G. Kaul, R. Manjithaya, S. Chopra, J. Haldar
ACS Chemical Biology, 2020, 15, 884-889.
20. Membrane-active rhamnolipids overcome aminoglycoside resistance
V. Yarlagadda, G. D. Wright
Cell Chemical Biology, 2019, 26, 1333-1334.
19. Vancomycin analogue restores meropenem activity against NDM-1 Gram-negative pathogens
V. Yarlagadda, P. Sarkar, S. Samaddar, G. B. Manjunath, S. D. Mitra, K. Paramanandham, B. R. Shome, J. Haldar
ACS Infectious Diseases 2018, 4, 1093-1101.
18. A vancomycin derivative with a pyrophosphate-binding group: A strategy to combat vancomycin-resistant bacteria. (Highlighted as a "Very important paper" in antibiotics)
V. Yarlagadda, P. Sarkar, S. Samaddar, J. Haldar
Angewandte Chemie International Edition, 2016, 27, 7836-7840.
17. A review on cell wall synthesis inhibitors with an emphasis on glycopeptide antibiotics
P. Sarkar, V. Yarlagadda, C. Ghosh, J. Haldar
MedChemComm, 2017, 8, 516-533.
16. Glycopeptide antibiotic to overcome the intrinsic resistance of Gram-negative bacteria
V. Yarlagadda, G. B. Manjunath, P. Sarkar, P. Akkapeddi, K. Paramanandham, S. B. Ranjan, R. Ravikumar, J. Haldar
ACS Infectious Diseases 2016, 2, 132-139.
15. Lipophilic vancomycin aglycon dimer with high activity against vancomycin-resistant bacteria
(Highlighted in Nature India "New defence against superbugs")
http://www.natureasia.com/en/nindia/article/10.1038/nindia.2015.151
V. Yarlagadda, P. Sarkar, G. B. Manjunath, J. Haldar
Bioorganic & Medicinal Chemistry Letters, 2015, 25, 5477-5480.
14. Intracellular activity of membrane active glycopeptide antibiotic (YV11455) against MRSA infection
V. Yarlagadda, S. Samaddar, J. Haldar
Journal of Global Antimicrobial Resistance, 2016, 5, 71-74.
13. Membrane disruption and enhanced inhibition of cell-wall biosynthesis: A synergistic approach to tackle vancomycin-resistant bacteria. (Highlighted as a "Hot paper" in drug design).
V. Yarlagadda, S. Samaddar, K. Paramanandham, B. R. Shome, J. Haldar
Angewandte Chemie International Edition 2015, 54, 13644-13649.
J. Hoque, M. M. Konai, S. Gonuguntla, G. B. Manjunath, Sandip Samaddar, V. Yarlagadda, J. Haldar
Journal of Medicinal Chemistry, 2015, 58, 5486-5500.
V. Yarlagadda, M. M. Konai, K. Paramanandham, V. C. Nimitha, B. R. Shome, J. Haldar
International Journal of Antimicrobial Agents, 2015, 46, 446-450.
J. Hoque, P. Akkapeddi, V. Yadav, G. B. Manjunath, D. S. S. M. Uppu, M. M. Konai, V. Yarlagadda, K. Sanyal, J. Haldar
ACS Applied Materials & Interfaces, 2015, 7, 1804-1815.
D. S. S. M. Uppu, G. B. Manjunath, V. Yarlagadda, J. E. Kaviyil, R. Ravikumar, K. Paramanandham, B. R. Shome, J. Haldar
PLoS ONE, 2015, 10, e0119422.
V. Yarlagadda, M. M. Konai, G. B. Manjunath, R. G. Prakash, B. Mani, K. Paramanandham, S. B. Ranjan, R. Ravikumar, S. P. Chakraborty, S. Roy, J. Haldar
International Journal of Antimicrobial Agents, 2015, 45, 627-634.
7. Tackling vancomycin-resistant bacteria with 'lipophilic-vancomycin-carbohydrate conjugates'.
V. Yarlagadda, M. M. Konai, G. B. Manjunath, C. Gosh, J. Haldar
The Journal of Antibiotics, 2015, 68, 302-312.
M. M. Konai, C. Ghosh, V. Yarlagadda, S. Samaddar, J. Haldar
Journal of Medicinal Chemistry, 2014, 57, 9409-9423.
5. Effect of amide bonds on the self-assembly of Gemini surfactants
J. Hoque, S. Gonuguntla, V. Yarlagadda, V. K. Aswal, J. Haldar
Physical Chemistry Chemical Physics, 2014, 16, 11279-11288.
4. Small molecular antibacterial peptoid mimics: The simpler the better!
C. Ghosh, G. B. Manjunath, P. Akkapeddi, V. Yarlagadda, J. Hoque, D. S. S. M. Uppu, M. M. Konai, J. Haldar
Journal of Medicinal Chemistry, 2014, 57, 1428-1436.
3. Membrane active vancomycin analogues: A strategy to combat bacterial resistance
V. Yarlagadda, P. Akkapeddi, G. B. Manjunath, J. Haldar
Journal of Medicinal Chemistry, 2014, 57, 4558-4568.
2. Polymers with tunable side-chain amphiphilicity as non-hemolytic antibacterial agents
D. S. S. M. Uppu, P. Akkapeddi, G. B. Manjunath, V. Yarlagadda, J. Hoque, J. Haldar
Chemical Communications, 2013, 49, 9389-9391.
1. Cleavable cationic antibacterial amphiphiles: Synthesis, mechanism of action, and cytotoxicities
J. Hoque, P. Akkapeddi, V. Yarlagadda, D. S. S. M. Uppu, P. Kumar, J. Haldar
Langmuir, 2012, 28, 12225-12234.